Combination of Osimertinib and Bevacizumab as First-line Treatment for Patients With Metastatic EGFR-Mutant Lung Cancers.
作者信息
Qi Chuang, Cui Huanxi, Chen Dongsheng
机构信息
The State Key Laboratory of Translational Medicine and Innovative Drug Development, Ministry of Science and Technology, Jiangsu Simcere Diagnostics Co, Ltd, Nanjing, China.
出版信息
JAMA Oncol. 2020 Dec 1;6(12):1982. doi: 10.1001/jamaoncol.2020.4818.
PMID:33119035
Abstract
摘要
Zotero 插件